Organisation
Medical Oncology
Current researchers
1 - 10 of 21 results
- Sandrine Aspeslagh (Member)
- Gil Awada (Member)
- Ruben De Wilde (Member)
- Lore Decoster (Member)
- Iris Dirven (Member)
- Christel Fontaine (Member)
- Mathijs Goossens (Member)
- Mark Gorris (Member)
- Sofie Joris (Member)
- Koen Kortbeek (Member)
Projects
1 - 2 of 2
- Health-related quality of life, psychosocial outcome and neurocognitive function in metastatic cancer survivors treated with immunotherapy, followed by integrative neurocognitive remediation therapyFrom1 Nov 2022 → TodayFunding: FWO fellowships
- A randomized phase II clinical trial in NSCLC combining SBRT and I.V. anti-PD-1 with or without I.T. anti-CTLA-4/anti-PD-L1 plus CD1c+ myDCFrom1 Oct 2019 → 30 Sep 2023Funding: FWO Applied Biomedical Research (TBM)
Publications
31 - 40 of 281
- Pretreatment with methanolic extract of Pistacia lentiscus L. increases sensitivity to DNA damaging drugs in primary high-grade serous ovarian cancer cells(2020)
Authors: Imane Charid, Mirjana Kessler, Silvia Darb-Esfahani, Tomasz Zemojtel, Salem Abobaker, Sandra Tuyaerts, Stefanine Schrauwen, Dina Atmani-Kilani, Nadjet Benaida-Debbache, Reinhold Schäfer, et al.
- Incidence of falls and fall-related injuries and their predictive factors in frail older persons with cancer(2022)
Authors: Cindy Kenis, Lore Decoster, Johan Flamaing, Philip R Debruyne, Inge De Groof, Christian Focan, Frank Cornélis, Vincent Verschaeve, Christian Bachmann, Dominique Bron, et al.
- Genomic Aberrations and Late Recurrence in Postmenopausal Women with Hormone Receptor-positive Early Breast Cancer(2021)
Authors: Elena Guerini-Rocco, Kathryn P Gray, Caterina Fumagalli, Marta Rita Reforgiato, Isabella Leone, Paola Rafaniello Raviele, Elisabetta Munzone, Roswitha Kammler, Patrick Neven, Erika Hitre, et al.
Pages: 504-512 - Intratumoral administration of CD1c (BDCA-1)+ and CD141 (BDCA-3)+ myeloid dendritic cells in combination with talimogene laherparepvec in immune checkpoint blockade refractory advanced melanoma patients(2022)
Authors: Julia Katharina Schwarze, Jens Tijtgat, Gil Awada, Louise Cras, Angela Vasaturo, Christopher Bagnall, Ramses Forsyth, Inès Dufait, Sandra Tuyaerts, Ivan Van Riet, et al.
Pages: 1-13 - First-in-human phase I study of the OX40 agonist GSK3174998 with or without pembrolizumab in patients with selected advanced solid tumors (ENGAGE-1)(2023)
Authors: Sophie Postel-Vinay, Vincent K Lam, Willeke Ros, Todd M Bauer, Aaron R Hansen, Daniel C Cho, F Stephen Hodi, Jan H.m. Schellens, Jennifer K Litton, Sandrine Aspeslagh, et al.
- MS1-Based Data Analysis Approaches for FFPE Tissue Imaging of Endogenous Peptide Ions by Mass Spectrometry Histochemistry (MSHC)(2023)
Authors: Nivedita Bhattacharya, Konstantin Nagornov, Kenneth Verheggen, Marthe Verhaert, Raf Sciot, Peter D E M Verhaert
Pages: 187-202 - Phase 2 Trial of Nivolumab Combined With Stereotactic Body Radiation Therapy in Patients With Metastatic or Locally Advanced Inoperable Melanoma(2019)
Authors: Nora Sundahl, Teofila Seremet, Jo Van Dorpe, B Neyns, Liesbeth Ferdinande, Annabel Meireson, Lieve Brochez, Vibeke Kruse, Piet Ost
Pages: 828-835 - Open-label, multicentre safety study of vemurafenib in 3219 patients with BRAFmutation-positive metastatic melanoma(2017)
Authors: Christian U Blank, James Larkin, Ana M Arance, Axel Hauschild, Paola Queirolo, Michele Del Vecchio, Paolo A Ascierto, Ivana Krajsova, Jacob Schachter, B Neyns, et al.
Pages: 176-184 - A Belgian Survey on Geriatric Assessment in Oncology Focusing on Large-Scale Implementation and Related Barriers and Facilitators(2016)
Authors: C. Kenis, P. Heeren, Lore Decoster, Katrien Van Puyvelde, G. Conings, Fabienne Cornelis, P. Cornette, R. Moor, S. Luce, Y. Libert, et al.
Pages: 60-70 - Advanced cutaneous squamous cell carcinoma of the head in two renal transplanted patients treated with cemiplimab(2022)
Authors: C Orte Cano, T Van Meerhaeghe, Julio Tannous, D. Lienard, Dirk Van Gestel, Nicolas Cuylits, S. Luce, S Carlot, A. Le Moine, Sandrine Aspeslagh, et al.
Pages: 53-58